Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function

Respiration

Volumn 81, Issue 6, 2011, Pages 499-510

  Poliska, Szilard ^a   Csanky, Eszter ^c,d   Szanto, Attila ^a   Szatmari, Istvan ^a   Mesko, Bertalan ^a   Szeles, Lajos ^a,b   Dezso, Balazs ^c   Scholtz, Beata ^a   Podani, Janos ^e   Kilty, Iain ^f   Takacs, Laszlo ^g   Nagy, Laszlo ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d Semmelweis Health Care Center   (Hungary)

^e EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^g Biosystems International SAS   (France)

Author keywords

Alveolar macrophages; Chronic obstructive pulmonary disease; Disease specific genes; FEV1; Lung function; Microarray; Monocytes

Indexed keywords

ADULT; AGED; ARTICLE; CELL TYPE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; MALE; MICROARRAY ANALYSIS; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79956118692     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000324297     Document Type: Article

References (50)

1. Barnes PJ: Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515-548. (Pubitemid 39658462)
2. Turato G, Zuin R, Saetta M: Pathogenesis and pathology of COPD. Respiration 2001;68:117-128. (Pubitemid 32260861)
3. Mannino DM: Epidemiology and global impact of chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005;26:204-210. (Pubitemid 40617297)
4. Reilly JJ: COPD and declining FEV1 - time to divide and conquer? N Engl J Med 2008;359:1616-1618.
5. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS: Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000;161:381-390. (Pubitemid 30129442)
6. Hogg JC: Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-721. (Pubitemid 39140629)
7. Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22:672-688. (Pubitemid 37258549)
8. van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008;75:224-238. (Pubitemid 351363881)
9. Stockley RA: Neutrophils and the pathogenesis of COPD. Chest 2002;121:151S-155S. (Pubitemid 34497333)
10. Kool M, Lambrecht BN: Dendritic cells in asthma and COPD: opportunities for drug development. Curr Opin Immunol 2007;19:701-710. (Pubitemid 350245749)
11. Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160: S29-S32.
12. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG: Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995;152:1666-1672. (Pubitemid 3002087)
13. Corrigan CJ, Kay AB: The roles of inf lammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1165-1168, discussion 1175-1166.
14. Shapiro SD, Ingenito EP: The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005;32:367-372. (Pubitemid 40629320)
15. Barnes PJ: Mechanisms in COPD: differences from asthma. Chest 2000;117:10S-14S. (Pubitemid 30111557)
16. Barnes PJ: Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183-192. (Pubitemid 351323287)
17. Kent L, Smyth L, Clayton C, Scott L, Cook T, Stephens R, Fox S, Hext P, Farrow S, Singh D: Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 2008;42:205-216.
18. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, Celli B, Brody JS: Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell Mol Biol 2004;31:601-610. (Pubitemid 39587489)
19. Golpon HA, Coldren CD, Zamora MR, Cosgrove GP, Moore MD, Tuder RM, Geraci MW, Voelkel NF: Emphysema lung tissue gene expression profiling. Am J Respir Cell Mol Biol 2004;31:595-600. (Pubitemid 39587488)
20. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM: Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004;101:14895-14900. (Pubitemid 39410771)
21. Harvey BG, Heguy A, Leopold PL, Carolan BJ, Ferris B, Crystal RG: Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med 2007;85:39-53. (Pubitemid 46020941)
22. Heguy A, O'Connor TP, Luettich K, Worgall S, Cieciuch A, Harvey BG, Hackett NR, Crystal RG: Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 2006;84:318-328.
23. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, Paquet AC, Erle DJ: A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005;172:1383-1392. (Pubitemid 43069811)
24. Meuronen A, Majuri ML, Alenius H, Mantyla T, Wolff H, Piirila P, Laitinen A: Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects. Respiration 2008;75:450-458. (Pubitemid 351685438)
25. Tsuji T, Aoshiba K, Nagai A: Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respirat ion 2010;80:59-70.
26. Elias JA, Schreiber AD, Gustilo K, Chien P, Rossman MD, Lammie PJ, Daniele RP: Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol 1985;135:3198-3204. (Pubitemid 16250579)
27. Covin RB, Brock TG, Bailie MB, Peters-Golden M: Altered expression and localization of 5-lipoxygenase accompany macrophage differentiation in the lung. Am J Physiol 1998;275: L303-L310.
28. Melis M, Pace E, Siena L, Spatafora M, Tipa A, Profita M, Bonanno A, Vignola AM, Bonsignore G, Mody CH, Gjomarkaj M: Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med 2003;167:1131-1138. (Pubitemid 36459661)
29. Schulz C, Wolf K, Harth M, Kratzel K, Kunz-Schughart L, Pfeifer M: Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. Respiration 2003;70:254-261. (Pubitemid 36980769)
30. Caruso M, Holgate ST, Polosa R: Adenosine signalling in airways. Curr Opin Pharmacol 2006;6:251-256. (Pubitemid 43670912)
31. Rennard SI: Inflammation and repair processes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160: S12-S16.
32. Wang H, Liu X, Umino T, Skold CM, Zhu Y, Kohyama T, Spurzem JR, Romberger DJ, Rennard SI: Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol 2001;25:772-779. (Pubitemid 33124695)
33. Hardie WD, Piljan-Gentle A, Dunlavy MR, Ikegami M, Korfhagen TR: Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha. Am J Physiol Lung Cell Mol Physiol 2001;281: L1088-L1094.
34. Richter A, O'Donnell RA, Powell RM, Sanders MW, Holgate ST, Djukanovic R, Davies DE: Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am J Respir Cell Mol Biol 2002;27:85-90. (Pubitemid 34657395)
35. Oudijk EJ, Nijhuis EH, Zwank MD, van de Graaf EA, Mager HJ, Coffer PJ, Lammers JW, Koenderman L: Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils. Thorax 2005;60:538-544. (Pubitemid 40966205)
36. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M: Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006;98:262-272. (Pubitemid 43264710)
37. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536. (Pubitemid 34130608)
38. Talbot SG, Estilo C, Maghami E, Sarkaria IS, Pham DK, Ocharoenrat P, Socci ND, Ngai I, Carlson D, Ghossein R, Viale A, Park BJ, Rusch VW, Singh B: Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res 2005;65:3063-3071. (Pubitemid 40524586)
39. Steele MP, Brown KK: Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration 2007;74:601-608. (Pubitemid 350164503)
40. Breuer RH, Postmus PE, Smit EF: Molecular pathology of non-small-cell lung cancer. Respiration 2005;72:313-330. (Pubitemid 40981094)
41. Schadt EE, Friend SH, Shaywitz DA: A network view of disease and compound screening. Nat Rev Drug Discov 2009;8:286-295.
42. Tilley AE, Harvey BG, Heguy A, Hackett NR, Wang R, O'Connor TP, Crystal RG: Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:457-466.
43. Kazeros A, Harvey BG, Carolan BJ, Vanni H, Krause A, Crystal RG: Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers. Am J Respir Cell Mol Biol 2008;39:747-757.
44. Meng QR, Gideon KM, Harbo SJ, Renne RA, Lee MK, Brys AM, Jones R: Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal Toxicol 2006;18:555-568. (Pubitemid 43977251)
45. Kent LM, Smyth LJ, Plumb J, Clayton CL, Fox SM, Ray DW, Farrow SN, Singh D: Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2, 6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7, 8-dihydropyrido [2, 3-d] pyrimidin-2-yl]amino}ethyl) guanidine (SB706504). J Pharmacol Exp Ther 2009;328:458-468.
46. Aldonyte R, Jansson L, Piitulainen E, Janciauskiene S: Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003;4:11.
47. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS: Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 2000;190:619-626. (Pubitemid 30164493)
48. Hashimoto S, Nakayama T, Gon Y, Hata N, Koura T, Maruoka S, Matsumoto K, Hayashi S, Abe Y, Horie T: Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1a (MIP-1α) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol 1998;111:604-610. (Pubitemid 28160908)
49. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Nolte IM, Boezen HM: Decorin and TGF-β1 polymorphisms and development of COPD in a general population. Respir Res 2006;7:89.
50. Tomaki M, Sugiura H, Koarai A, Komakiy Akita T, Matsumoto T, Nakanishi A, Ogawa H, Hattori T, Ichinose M: Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 2007;20:596-605. (Pubitemid 47077652)